We are live on ! Find out more
GCA

Greenwood Capital Associates Portfolio holdings

AUM $1.02B
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
-5.88%
1 Year Est. Return
+28.26%
3 Year Est. Return
+81.29%
5 Year Est. Return
+95.78%
10 Year Est. Return
+421.94%
AUM
$583M
AUM Growth
-$42M
Cap. Flow
+$4.78M
Cap. Flow %
0.82%
Top 10 Hldgs %
24.86%
Holding
234
New
30
Increased
81
Reduced
96
Closed
19

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$4.77M
2
CRSP icon
CRISPR Therapeutics
CRSP
+$4.35M
3
A icon
Agilent Technologies
A
+$3.46M
4
SPLK
Splunk Inc
SPLK
+$2.98M
5
CVS icon
CVS Health
CVS
+$2.59M

Top Sells

Rank Stock Value
1
WSM icon
Williams-Sonoma
WSM
+$5.15M
2
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$3.95M
3
CSCO icon
Cisco
CSCO
+$3.17M
4
DBX icon
Dropbox
DBX
+$2.89M
5
MU icon
Micron Technology
MU
+$2.29M

Sector Composition

Rank Sector Weight
1 Healthcare 19.13%
2 Technology 14.13%
3 Industrials 7.82%
4 Communication Services 6.8%
5 Energy 5.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTRA
126
DELISTED
Coterra Energy
CTRA
$829K 0.14%
+31,727
New +$909K
ASPN icon
127
Aspen Aerogels
ASPN
$510M
$828K 0.14%
89,767
-446
-0.5% -$5.4K
MX icon
128
Magnachip Semiconductor
MX
$139M
$824K 0.14%
80,488
-15
-0% -$197
EXP icon
129
Eagle Materials
EXP
$6.47B
$810K 0.14%
7,557
-97
-1% -$11.6K
ICLR icon
130
Icon
ICLR
$12.9B
$808K 0.14%
4,399
-61
-1% -$13.3K
VIAV icon
131
Viavi Solutions
VIAV
$10.6B
$805K 0.14%
61,691
-914
-1% -$13K
SWKH
132
DELISTED
SWK Holdings
SWKH
$801K 0.14%
59,441
+1,202
+2% +$16.7K
ILF icon
133
iShares Latin America 40 ETF
ILF
$3.71B
$796K 0.14%
33,477
-1,194
-3% -$28.5K
XIFR
134
XPLR Infrastructure LP
XIFR
$1.08B
$795K 0.14%
10,995
-98
-0.9% -$7.85K
JHG
135
DELISTED
Janus Henderson
JHG
$788K 0.14%
38,821
+917
+2% +$22.2K
STE icon
136
Steris
STE
$23.1B
$778K 0.13%
4,678
-1,638
-26% -$333K
KMB icon
137
Kimberly-Clark
KMB
$36.2B
$776K 0.13%
6,891
+40
+0.6% +$5.2K
LMT icon
138
Lockheed Martin
LMT
$140B
$762K 0.13%
+1,973
New +$824K
OMCL icon
139
Omnicell
OMCL
$1.69B
$759K 0.13%
8,719
-71
-0.8% -$7.46K
INFU icon
140
InfuSystem Holdings
INFU
$244M
$724K 0.12%
103,630
-1,871
-2% -$15.7K
HBIO icon
141
Harvard Bioscience
HBIO
$28.1M
$711K 0.12%
27,764
-386
-1% -$12.8K
RIO icon
142
Rio Tinto
RIO
$165B
$704K 0.12%
12,784
-9,710
-43% -$559K
EIDO icon
143
iShares MSCI Indonesia ETF
EIDO
$492M
$703K 0.12%
+30,130
New +$703K
OPRX icon
144
OptimizeRx
OPRX
$132M
$702K 0.12%
47,345
+14,111
+42% +$279K
PGTI
145
DELISTED
PGT, Inc.
PGTI
$697K 0.12%
33,248
-737
-2% -$15.1K
PG icon
146
Procter & Gamble
PG
$335B
$694K 0.12%
5,494
+14
+0.3% +$1.99K
SSB icon
147
SouthState Bank Corp
SSB
$10.7B
$694K 0.12%
8,766
– –
UTI icon
148
Universal Technical Institute
UTI
$1.41B
$691K 0.12%
127,070
+9,444
+8% +$66.1K
JYNT icon
149
The Joint Corp
JYNT
$123M
$681K 0.12%
43,358
+485
+1% +$8.63K
CTLP
150
DELISTED
Cantaloupe
CTLP
$678K 0.12%
194,900
+1,576
+0.8% +$8.65K
4 5
6
7 8

Similar funds

SVCP
Silicon Valley Capital Partners San Jose, California $1.02B AUM 21.85% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $1.02B AUM
CC
Crosslink Capital Menlo Park, California $1.02B AUM 9.21% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Greenwood Capital Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Greenwood Capital Associates held 234 positions worth $583M, down 6.7% from $625M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Greenwood Capital Associates's Q3 2022 filing shows 30 new, 81 increased, 96 reduced and 19 closed positions. Its largest new stake was CRISPR Therapeutics: 60,055 shares worth $3.92M. The largest sale was Williams-Sonoma, an estimated $5.15M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

  • Greenwood Capital Associates's largest Q3 2022 buy was CRISPR Therapeutics: 60,055 shares worth $3.92M.
  • Greenwood Capital Associates added most to iShares Core S&P 500 ETF in Q3 2022, an estimated $4.77M increase.
  • Greenwood Capital Associates's biggest Q3 2022 reduction was Williams-Sonoma, cutting an estimated $5.15M.
  • Greenwood Capital Associates fully exited Electronic Arts in Q3 2022, selling an estimated $1.69M.
  • Greenwood Capital Associates's ten largest holdings make up 25% of its $583M portfolio in Q3 2022.
  • Greenwood Capital Associates opened 30 new positions and closed 19 in Q3 2022.
  • Greenwood Capital Associates's portfolio value fell 6.7% quarter-over-quarter to $583M.

Based on Greenwood Capital Associates's 13F filing for Q3 2022, filed 10 Nov 2022.